Senores Pharmaceuticals Ltd

SENORES

Company Profile

  • Business description

    Senores Pharmaceuticals Ltd is a research-driven pharmaceutical company engaged in developing and manufacturing a wide range of pharmaceutical products predominantly for the Regulated Markets of the USA, Canada and United Kingdom across various therapeutic areas and dosage forms, with a presence in Emerging Markets. Its strength lies in identifying, developing and manufacturing a diverse range of specialty, underpenetrated and complex pharmaceutical products establishing the company as a preferred partner to certain customers. Through data analytics, research, market assessment and experienced management, It strategically identifies commercially underpenetrated molecules to launch products in the Regulated and Emerging Markets.

  • Contact

    Ambali Bopal Road
    1101 to 1103, 11th floor, South Tower, ONE 42
    Opposite Jayantilal Park
    AhmedabadGJ380054
    IND

    T: +91 7929999857

    https://www.senorespharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 March 2027

    Employees

    194

Stocks News & Analysis

stocks

Older cohorts the budget losers, not necessarily the ASX listed insurers

Proposed legislation removes health insurance rebates.
stocks

Turnaround progressing for ASX share

Margins have rebased by shares are undervalued.
stocks

Investors overlooking ASX share’s potential

International expansion is a distraction from valuable local business.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,735.4083.10-0.94%
CAC 407,987.4934.940.44%
DAX 4024,307.92357.351.49%
Dow JONES (US)49,614.6488.470.18%
FTSE 10010,323.75128.381.26%
HKSE25,675.18287.55-1.11%
NASDAQ26,046.02179.13-0.68%
Nikkei 22560,815.95593.34-0.97%
NZX 50 Index12,762.92202.09-1.56%
S&P 5007,391.8716.63-0.22%
S&P/ASX 2008,505.3072.60-0.85%
SSE Composite Index4,131.533.86-0.09%

Market Movers